ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
65.57
+1.14 (1.77%)
At close: Oct 8, 2025, 4:00 PM EDT
65.57
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:15 PM EDT
BIB Holdings Information
BIB is an equity ETF with a total of 259 individual holdings.
Total Holdings
259
Top 10 Percentage
152.59%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
62.42M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 29.88% |
| 2 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 24.77% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 22.19% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 21.27% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 20.19% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 15.60% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 5.11% |
| 8 | GILD | Gilead Sciences, Inc. | 5.03% |
| 9 | AMGN | Amgen Inc. | 5.00% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.55% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.52% |
| 12 | AZN | AstraZeneca PLC | 2.62% |
| 13 | INSM | Insmed Incorporated | 2.02% |
| 14 | ARGX | argenx SE | 1.44% |
| 15 | BIIB | Biogen Inc. | 1.31% |
| 16 | UTHR | United Therapeutics Corporation | 1.22% |
| 17 | INCY | Incyte Corporation | 1.00% |
| 18 | SMMT | Summit Therapeutics Inc. | 0.97% |
| 19 | TEM | Tempus AI, Inc. | 0.92% |
| 20 | RPRX | Royalty Pharma plc | 0.92% |
| 21 | MEDP | Medpace Holdings, Inc. | 0.88% |
| 22 | ILMN | Illumina, Inc. | 0.87% |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 0.80% |
| 24 | SNY | Sanofi | 0.78% |
| 25 | ASND | Ascendis Pharma A/S | 0.75% |
As of Oct 7, 2025